March 28, 2022
Oxbow Partnering with Medgene Labs to Donate Doses of RHDV-2 Vaccine (Emergency Use Authorization)
Oxbow Animal Health is partnering with Medgene Labs (Brookings, SD) to donate 2,000 doses of Rabbit Hemorrhagic Disease Virus (RHDV-2) vaccine (emergency use authorization) to support rabbit vaccination clinics across the United States. Rabbit Hemorrhagic Disease (RHD) is a usually fatal disease affecting wild and domestic rabbits and is caused by Rabbit Hemorrhagic Disease Viruses. Major outbreaks of RHDV-2 have occurred in wild and domestic rabbits in North America since 2020.
Organizations eligible to apply for RHDV-2 vaccine (emergency use authorization) doses may include rescue groups and/or veterinarians and must meet the following requirements:
1. Must reside in a state that has approved distribution of the Medgene RHDV-2 vaccine (emergency use authorization).
2. Must have a veterinarian identified to procure and administer vaccinations.
3. Must have a minimum of 10 rabbits to vaccinate within a 24 hour period.
Applications should be submitted online and will be accepted through April 30, 2022.
To learn more and apply, visit bit.ly/3DgY4eE.
“At Oxbow, we’re committed to growing the good for the animals we serve and the caretakers who love them,” said Melissa Ross, Oxbow’s Vice President of Marketing. “To us, this commitment means identifying animals in need and using our resources to support them. With this in mind, we are delighted to partner with Medgene Labs to donate and distribute 2,000 doses of RHDV-2 vaccine (emergency use authorization) to support vaccination clinics across the U.S. These doses will help ensure that 1,000 domestic rabbits are protected from RHDV-2.”
Learn more about RHDV-2.
Learn what Oxbow is doing to keep your rabbits safe from RHDV-2.